Certain A Shares of Nanjing Well Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 30-JAN-2022.
January 29, 2022
Share
Certain A Shares of Nanjing Well Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 30-JAN-2022. These A Shares will be under lockup for 1110 days starting from 16-JAN-2019 to 30-JAN-2022.
Details:
The controlling shareholders Wu Renrong, Gao Zhengsong and Chen Xinguo and Huasun Co., Ltd, Shuntai Zonghua Investments, Tang Qunsong and Zou Jianguo, shareholders and managers of the company committed that within 36 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the company.
The supervisors Wu Rongwen and Li Youhong and the other shareholders namely Jiangsu Talent Investments Co., Ltd, Beijing Runxin Dingtai Co., Ltd, Jiangsu Gao Investments Co., Ltd, Wuxi Runxin Investments Co., Ltd, Chen Jiusi, Jia Jianguo, Hong Shilin and Wu Qun committed that within 12 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the company.
Nanjing Well Pharmaceutical Group Co Ltd, formerly Nanjing Well Pharmaceutical Co Ltd, is a China-based company principally involved in the research and development, manufacturing and sales of pharmaceutical auxiliary materials and synthetic lubricating base oil products. Its main products include pharmaceutical auxiliary materials, synthetic lubricating base oil and pesticide additives. The Company distributes its products primarily in domestic market.